The Development and Characterization of a Human Mesothelioma In Vitro 3D Model to Investigate Immunotoxin Therapy
2011

3D Model of Human Mesothelioma to Study Immunotoxin Therapy

publication Evidence: moderate

Author Information

Author(s): Xiang Xinran, Phung Yen, Feng Mingqian, Nagashima Kunio, Zhang Jingli, Broaddus V. Courtney, Hassan Raffit, FitzGerald David, Ho Mitchell

Primary Institution: Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

Hypothesis

How does the tumor microenvironment affect the penetration and killing activity of the immunotoxin SS1P in mesothelioma?

Conclusion

The study found that SS1P was significantly less effective in killing mesothelioma cells grown as spheroids compared to those grown as monolayers due to poor penetration.

Supporting Evidence

  • Spheroids were at least 100 times less affected by SS1P compared to monolayers.
  • Fluorescence microscopy showed limited penetration of SS1P within spheroids after 4 hours.
  • E-Cadherin expression was significantly increased in spheroids compared to monolayers.

Takeaway

Researchers created a 3D model of mesothelioma to see how well a cancer drug can get inside and kill the cancer cells. They found that the drug couldn't get in very well, so it didn't work as effectively.

Methodology

The study used a 3D spheroid model of human mesothelioma cells to assess the penetration and efficacy of the immunotoxin SS1P.

Limitations

The study primarily focused on a specific cell line and may not fully represent the complexity of all mesothelioma tumors.

Participant Demographics

The study involved human mesothelioma cell lines and primary cell lines from patients.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pone.0014640

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication